<code id='E95819197A'></code><style id='E95819197A'></style>
    • <acronym id='E95819197A'></acronym>
      <center id='E95819197A'><center id='E95819197A'><tfoot id='E95819197A'></tfoot></center><abbr id='E95819197A'><dir id='E95819197A'><tfoot id='E95819197A'></tfoot><noframes id='E95819197A'>

    • <optgroup id='E95819197A'><strike id='E95819197A'><sup id='E95819197A'></sup></strike><code id='E95819197A'></code></optgroup>
        1. <b id='E95819197A'><label id='E95819197A'><select id='E95819197A'><dt id='E95819197A'><span id='E95819197A'></span></dt></select></label></b><u id='E95819197A'></u>
          <i id='E95819197A'><strike id='E95819197A'><tt id='E95819197A'><pre id='E95819197A'></pre></tt></strike></i>

          Home / comprehensive / leisure time

          leisure time


          leisure time

          author:entertainment    Page View:322
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In